Was sind die meistzitierten Publikationen aus dem Bereich Multiple Sklerose (MS)? Was ist der Inhalt dieser Artikel? Wer sind die Autoren? Wo und wann sind die Artikel erschienen?
Mich hat diese Frage einmal wunder genommen. So habe ich in der Web of Science Datenbank von Thomson Reuters nach allen Multiple Sklerose Publikationen gesucht. Die Web of Science Datenbank erfasst die wissenschaftlichen Publikationen mit ihren Zusatzdaten wie Autoren, Referenzen und Sponsoren. Als Zitationen werden Referenzen bzw. Verweise auf andere wissenschaftliche Publikationen bezeichnet. Zitationen und Publikationen können mit der Web of Science Datenbank analysiert werden. Auf wichtige, spannende oder kontroverse Artikel wird häufiger Bezug genommen. Der Artikel Was ist gute Wissenschaft? befasst sich ebenfalls mit dieser Publikationsdatenbank und der Zitationsanalyse.
Bei meiner Anfrage wurden in der Datenbank 51’539 Publikationen zum Thema Multiple Sklerose gefunden. In der Tabelle sind die 50 meistzitierten Publikationen aufgelistet.
| Nr. | Publikationstitel Anzahl Zitationen Erscheinungsjahr und Fachzeitschrift Autoren |
|---|---|
| 1. | NEW DIAGNOSTIC-CRITERIA FOR MULTIPLE-SCLEROSIS – GUIDELINES FOR RESEARCH PROTOCOLS 5637 times cited 1983 Annals Of Neurology Poser, Cm; Paty, Dw; Scheinberg, L; Mcdonald, Wi; Davis, Fa; Ebers, Gc; Johnson, Kp; Sibley, Wa; Silberberg, Dh; Tourtellotte, Ww |
| 2. | RATING NEUROLOGIC IMPAIRMENT IN MULTIPLE-SCLEROSIS – AN EXPANDED DISABILITY STATUS SCALE (EDSS) 4714 times cited 1983 Neurology Kurtzke, Jf |
| 3. | Recommended diagnostic criteria for multiple sclerosis: Guidelines from the International Panel on the Diagnosis of Multiple Sclerosis 2505 times cited 2001 Annals Of Neurology Mcdonald, Wi; Compston, A; Edan, G; Goodkin, D; Hartung, Hp; Lublin, Fd; Mcfarland, Hf; Paty, Dw; Polman, Ch; Reingold, Sc; Sandberg-Wollheim, M; Sibley, W; Thompson, Aj; Van Den Noort, S; Weinshenker, By; Wolinsky, Js |
| 4. | Axonal transection in the lesions of multiple sclerosis 1884 times cited 1998 New England Journal Of Medicine Trapp, Bd; Peterson, J; Ransohoff, Rm; Rudick, R; Mork, S; Bo, L |
| 5. | Vitamin D deficiency 1441 times cited 2007 New England Journal Of Medicine Holick, Mf |
| 6. | Defining the clinical course of multiple sclerosis: Results of an international survey 1432 times cited 1996 Neurology Lublin, Fd; Reingold, Sc |
| 7. | Intramuscular interferon beta-1 alpha for disease progression in relapsing multiple sclerosis 1381 times cited 1996 Annals Of Neurology Jacobs, Ld; Cookfair, Dl; Rudick, Ra; Herndon, Rm; Richert, Jr; Salazar, Am; Fischer, Js; Goodkin, De; Granger, Cv; Simon, Jh; Alam, Jj; Bartoszak, Dm; Bourdette, Dn; Braiman, J; Brownscheidle, Cm; Coats, Me; Cohan, Sl; Dougherty, Ds; Kinkel, Rp; Mass, Mk; Munschauer, Fe; Priore, Rl; Pullicino, Pm; Scherokman, Bj; Weinstockguttman, B; Whitman, Rh; Baird, Wc; Fillmore, M; Bona, Lm; Colonruiz, Me; Nadine, Bs; Donovan, A; Bennett, S; Kieffer, Ym; Umhauer, Ma; Miller, Ce; Kilic, Ak; Sargent, El; Schachter, M; Shucard, Dw; Weider, V; Catalano, Ba; Cervi, Jm; Czekay, C; Farrell, Jl; Filippini, Js; Matyas, Rc; Michienzi, Ke; Ito, M; Omalley, Ja; Zielezny, Ma; Brun, Jm; Davidson, Al; Green, La; Oreilly, Km; Shelton, Ja; Wende, Ke; Barilla, Dy; Boyle, Sl; Perkins, Kk; Perryman, Je; Stiebeling, Bg; Konecsni, Jf; Ross, Js; Choi, Ks; Gustafson, Cj; Quandt, Bj; Scherzinger, Al; Griffith, Da; Harris, Jm; Lezak, Md; Mimica, I; Saunders, Ja; Coit, We; Force, Cr; Gilmore, Fj; Harris, Lb; Jones, Mm; Kauffman, Ja; Marberger, Ke; Mcbride, Jw; Miller, Ll; Wright, Gk; Brooks, Ja; Brown, Hr; Graves, Me; Schmidt, Ja; Mothena, Jw; Grafman, Jh; Kenworthy, Mk; Morton, Mm; Brown, Dm; Brown, Dc; Levy, Lm; Borden, Ec; Ransohoff, Rm; Vilcek, Jt; Mccarthykirby, K; Campion, M |
| 8. | REGULATORY T-CELL CLONES INDUCED BY ORAL TOLERANCE – SUPPRESSION OF AUTOIMMUNE ENCEPHALOMYELITIS 1378 times cited 1994 Science Chen, Yh; Kuchroo, Vk; Inobe, J; Hafler, Da; Weiner, Hl |
| 9. | IL-23 drives a pathogenic T cell population that induces autoimmune inflammation 1249 times cited 2005 Journal Of Experimental Medicine Langrish, Cl; Chen, Y; Blumenschein, Wm; Mattson, J; Basham, B; Sedgwick, Jd; Mcclanahan, T; Kastelein, Ra; Cua, Dj |
| 10. | INTERFERON BETA-1B IS EFFECTIVE IN RELAPSING-REMITTING MULTIPLE-SCLEROSIS – CLINICAL-RESULTS OF A MULTICENTER, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED TRIAL 1238 times cited 1993 Neurology Duquette, P; Girard, M; Despault, L; Dubois, R; Knobler, Rl; Lublin, Fd; Kelley, L; Francis, Gs; Lapierre, Y; Antel, J; Freedman, M; Hum, S; Greenstein, Ji; Mishra, B; Muldoon, J; Whitaker, Jn; Evans, Bk; Layton, B; Sibley, Wa; Laguna, J; Krikawa, J; Paty, Dw; Oger, Jj; Kastrukoff, Lf; Moore, Grw; Hashimoto, Sa; Morrison, W; Nelson, J; Goodin, Ds; Massa, Sm; Gutteridge, E; Arnason, Bgw; Noronha, A; Reder, At; Martia, R; Ebers, Gc; Rice, Gpa; Lesaux, J; Johnson, Kp; Panitch, Hs; Bever, Ct; Conway, K; Wallenberg, Jc; Bedell, L; Vandennoort, S; Weinshenker, B; Weiss, W; Reingold, S; Pachner, A; Taylor, W |
| 11. | Medical progress: Multiple sclerosis. 1174 times cited 2000 New England Journal Of Medicine Noseworthy, Jh; Lucchinetti, C; Rodriguez, M; Weinshenker, Bg |
| 12. | Heterogeneity of multiple sclerosis lesions: Implications for the pathogenesis of demyelination 1059 times cited 2000 Annals Of Neurology Lucchinetti, C; Bruck, W; Parisi, J; Scheithauer, B; Rodriguez, M; Lassmann, H |
| 13. | Diagnostic criteria for multiple sclerosis: 2005 Revisions to the “McDonald Criteria” 1050 times cited 2005 Annals Of Neurology Polman, Ch; Reingold, Sc; Edan, G; Filippi, M; Hartung, Hp; Kappos, L; Lublin, Fd; Metz, Lm; Mcfarland, Hf; O’Connor, Pw; Sandberg-Wollheim, M; Thompson, Aj; Weinshenker, Bg; Wolinsky, Js |
| 14. | Randomised double-blind placebo-controlled study of interferon beta-1a in relapsing/remitting multiple sclerosis 1043 times cited 1998 Lancet Ebers, Gc; Rice, G; Lesaux, J; Paty, D; Oger, J; Li, Dkb; Beall, S; Devonshire, V; Hashimoto, S; Hooge, J; Kastrukoff, L; Krieger, C; Mezei, M; Seland, P; Vorobeychi, G; Morrison, W; Nelson, J; Freedman, Ms; Chrisie, S; Nelson, R; Rabinovitch, H; Freedman, C; Hartung, Hp; Rieckmann, P; Archelos, J; Jung, S; Weilbach, F; Flachenecke, P; Sauer, J; Hommes, O; Jongen, P; Brouwer, S; Mcleod, J; Pollard, J; Ng, R; Sandberg-Wollheim, M; Kallen, K; Nilsson, P; Ekberg, R; Lundgren, A; Jadback, G; Wikstrom, J; Multanen, J; Valjakka, M; Carton, H; Lissoir, F; Declerq, I; Vieren, M; Peeters, E; Dubois, B; Dekeersmaeker, E; Van Herle, A; Hughes, Rac; Sharrack, B; Soudain, S; Panelius, M; Eralinna, J; Soilu-Hanninen, M; Murto, S; Medaer, R; Broeckx, J; Vanroose, E; Bogaers, A; Blumhardt, Ld; Edwards, S; Liu, C; Orpe, V; Barnes, D; Schwartz, M; Stoy, N; Harraghy, C; Bertelsmann, F; Uitdehaag, B; Nasseri, K; Chofflon, M; Roth, S; Kappos, L; Huber, S; Bellaiche, Y; Senn, C; King, J; Jubert, J; Whitten, S; Newsom-Davis, Jm; Palace, J; Lee, M; Evangelou, N; Pinto, A; Cavey, A; Sindic, Cjm; Monteyne, P; Verougstraete, D; Van Doorn, Pa; Moll, W; Visser, L; Willems, M; Martina, I; Buljevac, D; Loman, L; Bates, D; Pandit, D; Irving, J; Rhodes, B; Riddehough, A; Zhao, Gj; Wang, X; Cheng, Y; Ammoury, N; Dupont, F; Galazka, A; Hyde, R; Olson, M; Pernin, Mo; Abdul-Ahad, Ak; Hommes, O; Noseworthy, J; Borden, E; O’Brien, P; Wolinsky, J |
| 15. | PROBLEMS OF EXPERIMENTAL TRIALS OF THERAPY IN MULTIPLE SCLEROSIS – REPORT BY PANEL ON EVALUATION OF EXPERIMENTAL TRIALS OF THERAPY IN MULTIPLE SCLEROSIS 1039 times cited 1965 Annals Of The New York Academy Of Sciences Schumach.Ga; Beebe, G; Kibler, Rf; Kurland, Lt; Kurtzke, Jf; Mcdowell, F; Nagler, B; Sibley, Wa; Tourtell.Ww; Willmon, Tl |
| 16. | THE FATIGUE SEVERITY SCALE – APPLICATION TO PATIENTS WITH MULTIPLE-SCLEROSIS AND SYSTEMIC LUPUS-ERYTHEMATOSUS 1028 times cited 1989 Archives Of Neurology Krupp, Lb; Larocca, Ng; Muirnash, J; Steinberg, Ad |
| 17. | PREVENTION OF EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS BY ANTIBODIES AGAINST ALPHA-4-BETA-1 INTEGRIN 943 times cited 1992 Nature Yednock, Ta; Cannon, C; Fritz, Lc; Sanchezmadrid, F; Steinman, L; Karin, N |
| 18. | MOLECULAR MIMICRY IN T-CELL-MEDIATED AUTOIMMUNITY – VIRAL PEPTIDES ACTIVATE HUMAN T-CELL CLONES SPECIFIC FOR MYELIN BASIC-PROTEIN 937 times cited 1995 Cell Wucherpfennig, Kw; Strominger, Jl |
| 19. | COPOLYMER-1 REDUCES RELAPSE RATE AND IMPROVES DISABILITY IN RELAPSING-REMITTING MULTIPLE-SCLEROSIS – RESULTS OF A PHASE-III MULTICENTER, DOUBLE-BLIND, PLACEBO-CONTROLLED TRIAL 923 times cited 1995 Neurology Johnson, Kp; Brooks, Br; Cohen, Ja; Ford, Cc; Goldstein, J; Lisak, Rp; Myers, Lw; Panitch, Hs; Rose, Jw; Schiffer, Rb; Vollmer, T; Weiner, Lp; Wolinsky, Js; Bird, Sj; Constantinescu, C; Kolson, Dl; Gonzalezscarano, F; Brennan, D; Pfohl, D; Mandler, Rn; Rosenberg, Ga; Jeffrey, C; Barger, Gr; Gandhi, B; Moore, Pm; Rogers, Lr; Lisak, D; Smith, L; Ellison, Gw; Baumhefner, Rw; Craig, Sl; Jalbut, Ss; Katz, E; Conway, Kl; Burns, Jb; Shiba, C; Giang, Dw; Petrie, Md; Guarnaccia, Jb; Anderson, S; Mckeon, A; Mccarthy, M; Thomas, Ab; Vriesendorp, Fj; Austin, Sg; Lindsey, Jw; Dimachkie, M; Cerreta, E; Kachuck, N; Mccarthy, Ka; Fleming, J; Parnell, Jh; Tamulevich, J; Weasler, C; Kadosh, S; Halt, H; Stark, Y; Pinchasi, I; Spiller, N; Vandennoort, S; Miller, A; Mellits, D; Hopkins, J; Reingold, S; Gomolin, Ih |
| 20. | PROCESSING OF TUMOR-NECROSIS-FACTOR-ALPHA PRECURSOR BY METALLOPROTEINASES 911 times cited 1994 Nature Gearing, Ajh; Beckett, P; Christodoulou, M; Churchill, M; Clements, J; Davidson, Ah; Drummond, Ah; Galloway, Wa; Gilbert, R; Gordon, Jl; Leber, Tm; Mangan, M; Miller, K; Nayee, P; Owen, K; Patel, S; Thomas, W; Wells, G; Wood, Lm; Woolley, K |
| 21. | INTERFERON BETA-1B IS EFFECTIVE IN RELAPSING-REMITTING MULTIPLE-SCLEROSIS .2. MRI ANALYSIS RESULTS OF A MULTICENTER, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED TRIAL 892 times cited 1993 Neurology Paty, Dw; Li, Dkb; Duquette, P; Girard, M; Despault, L; Dubois, R; Knobler, Rl; Lublin, Fd; Kelley, L; Francis, Gs; Lapierre, Y; Antel, J; Freedman, M; Hum, S; Greenstein, Ji; Mishra, B; Muldoon, J; Whitaker, Jn; Evans, Bk; Layton, B; Sibley, Wa; Laguna, J; Krikawa, J; Paty, Dw; Oger, Jj; Kastrukoff, Lf; Moore, Grw; Hashimoto, Sa; Morrison, W; Nelson, J; Goodin, Ds; Massa, Sm; Gutteridge, E; Arnason, Bgw; Noronha, A; Reder, At; Martia, R; Ebers, Gc; Rice, Gpa; Lesaux, J; Johnson, Kp; Panitch, Hs; Bever, Ct; Conway, K; Wallenberg, Jc; Bedell, L; Vandennoort, S; Weinshenker, B; Weiss, W; Reingold, S; Pachner, A; Taylor, W |
| 22. | Apoptosis in the nervous system 890 times cited 2000 Nature Yuan, Jy; Yankner, Ba |
| 23. | AN ADVERSE PROPERTY OF A FAMILIAL ALS-LINKED SOD1 MUTATION CAUSES MOTOR-NEURON DISEASE CHARACTERIZED BY VACUOLAR DEGENERATION OF MITOCHONDRIA 837 times cited 1995 Neuron Wong, Pc; Pardo, Ca; Borchelt, Dr; Lee, Mk; Copeland, Ng; Jenkins, Na; Sisodia, Ss; Cleveland, Dw; Price, Dl |
| 24. | Principles of interleukin (IL)-6-type cytokine signalling and its regulation 831 times cited 2003 Biochemical Journal Heinrich, Pc; Behrmann, I; Haan, S; Hermanns, Hm; Muller-Newen, G; Schaper, F |
| 25. | The interleukin-12/interleukin-12-receptor system: Role in normal and pathologic immune responses 808 times cited 1998 Annual Review Of Immunology Gately, Mk; Renzetti, Lm; Magram, J; Stern, As; Adorini, L; Gubler, U; Presky, Dh |
| 26. | LYMPHOCYTE-T ENTRY INTO THE CENTRAL-NERVOUS-SYSTEM 798 times cited 1991 Journal Of Neuroscience Research Hickey, Wf; Hsu, Bl; Kimura, H |
| 27. | IMMUNOLOGICAL ASPECTS OF DEMYELINATING DISEASES 788 times cited 1992 Annual Review Of Immunology Martin, R; Mcfarland, Hf; Mcfarlin, De |
| 28. | COGNITIVE DYSFUNCTION IN MULTIPLE-SCLEROSIS .1. FREQUENCY, PATTERNS, AND PREDICTION 782 times cited 1991 Neurology Rao, Sm; Leo, Gj; Bernardin, L; Unverzagt, F |
| 29. | PRELIMINARY TRIAL OF CARISOPRODOL IN MULTIPLE SCLEROSIS 779 times cited 1964 Practitioner Ashworth, B |
| 30. | Axonal damage in acute multiple sclerosis lesions 778 times cited 1997 Brain Ferguson, B; Matyszak, Mk; Esiri, Mm; Perry, Vh |
| 31. | ORAL TOLERANCE – IMMUNOLOGICAL MECHANISMS AND TREATMENT OF ANIMAL AND HUMAN ORGAN-SPECIFIC AUTOIMMUNE-DISEASES BY ORAL-ADMINISTRATION OF AUTOANTIGENS 767 times cited 1994 Annual Review Of Immunology Weiner, Hl; Friedman, A; Miller, A; Khoury, Sj; Alsabbagh, A; Santos, L; Sayegh, M; Nussenblatt, Rb; Trentham, De; Hafler, Da |
| 32. | INTERFERON BETA-1B IN THE TREATMENT OF MULTIPLE-SCLEROSIS – FINAL OUTCOME OF THE RANDOMIZED CONTROLLED TRIAL 748 times cited 1995 Neurology Duquette, P; Despault, L; Knobler, Rl; Lublin, Fd; Kelley, L; Francis, Gs; Freedman, M; Lapierre, Y; Greenstein, Ji; Mishra, B; Delillio, N; Whitaker, J; Layton, B; Sibley, Wa; Laguna, J; Krikawa, J; Paty, Dw; Oger, Jj; Kastrukoff, Lf; Morrison, W; Nelson, J; Goodin, D; Massa, Sm; Gutteridge, E; Arnason, Bgw; Noronha, A; Reder, At; Martia, R; Ebers, Gc; Rice, Gpa; Lesaux, J; Johnson, Kp; Panitch, Hs; Bever, Ct; Conway, K; Li, Dkb; Tanton, El; Zhao, Gj; Flak, B; Riddehough, A; Cover, K; Rhodes, B; Cook, A; Smith, K; Costley, L; Renneberg, S; Shaw, T; Genton, M; Vandennoort, S; Weinshenker, B; Weiss, W; Reingold, S; Taylor, W; Wallenberg, Jc; Bedell, L |
| 33. | Mechanisms of disease: The effect of infections on susceptibility to autoimmune and allergic diseases 719 times cited 2002 New England Journal Of Medicine Bach, Jf |
| 34. | Chemokines and disease 712 times cited 2001 Nature Immunology Gerard, C; Rollins, Bj |
| 35. | CD127 expression inversely correlates with FoxP3 and suppressive function of human CD4(+) T reg cells 688 times cited 2006 Journal Of Experimental Medicine Liu, Wh; Putnam, Al; Xu-Yu, Z; Szot, Gl; Lee, Mr; Zhu, S; Gottlieb, Pa; Kapranov, P; Gingeras, Tr; Fazekas De St Groth, B; Clayberger, C; Soper, Dm; Ziegler, Sf; Bluestone, Ja |
| 36. | Loss of functional suppression by CD4(+)CD25(+) regulatory T cells in patients with multiple sclerosis 686 times cited 2004 Journal Of Experimental Medicine Viglietta, V; Baecher-Allan, C; Weiner, Hl; Hafler, Da |
| 37. | The glial scar and central nervous system repair 682 times cited 1999 Brain Research Bulletin Fawcett, Jw; Asher, Ra |
| 38. | Intramuscular interferon beta-1a therapy initiated during a first demyelinating event in multiple sclerosis. 676 times cited 2000 New England Journal Of Medicine Jacobs, Ld; Beck, Rw; Simon, Jh; Kinkel, Rp; Brownscheidle, Cm; Murray, Tj; Simonian, Na; Slasor, Pj; Sandrock, Aw |
| 39. | Diffusion tensor imaging: Concepts and applications 671 times cited 2001 Journal Of Magnetic Resonance Imaging Le Bihan, D; Mangin, Jf; Poupon, C; Clark, Ca; Pappata, S; Molko, N; Chabriat, H |
| 40. | THE NATURAL-HISTORY OF MULTIPLE-SCLEROSIS – A GEOGRAPHICALLY BASED STUDY 668 times cited 1989 Brain Weinshenker, Bg; Bass, B; Rice, Gpa; Noseworthy, J; Carriere, W; Baskerville, J; Ebers, Gc |
| 41. | TNF-R1 signaling: A beautiful pathway 667 times cited 2002 Science Chen, Gq; Goeddel, Dv |
| 42. | T-CELL RECOGNITION OF AN IMMUNODOMINANT MYELIN BASIC-PROTEIN EPITOPE IN MULTIPLE-SCLEROSIS 655 times cited 1990 Nature Ota, K; Matsui, M; Milford, El; Mackin, Ga; Weiner, Hl; Hafler, Da |
| 43. | ORAL TOLERANCE TO MYELIN BASIC-PROTEIN AND NATURAL RECOVERY FROM EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS ARE ASSOCIATED WITH DOWN-REGULATION OF INFLAMMATORY CYTOKINES AND DIFFERENTIAL UP-REGULATION OF TRANSFORMING GROWTH-FACTOR-BETA, INTERLEUKIN-4, AND PROSTAGLANDIN-E EXPRESSION IN THE BRAIN 652 times cited 1992 Journal Of Experimental Medicine Khoury, Sj; Hancock, Ww; Weiner, Hl |
| 44. | Interleukin-23 promotes a distinct CD4 T cell activation state characterized by the production of interleukin-17 635 times cited 2003 Journal Of Biological Chemistry Aggarwal, S; Ghilardi, N; Xie, Mh; De Sauvage, Fj; Gurney, Al |
| 45. | A randomized, placebo-controlled trial of natalizumab for relapsing multiple sclerosis 622 times cited 2006 New England Journal Of Medicine Polman, Ch; O’Connor, Pw; Havrdova, E; Hutchinson, M; Kappos, L; Miller, Dh; Phillips, Jt; Lublin, Fd; Giovannoni, G; Wajgt, A; Toal, M; Lynn, F; Panzara, Ma; Sandrock, Aw |
| 46. | THE MULTIDIMENSIONAL FATIGUE INVENTORY (MFI) PSYCHOMETRIC QUALITIES OF AN INSTRUMENT TO ASSESS FATIGUE 618 times cited 1995 Journal Of Psychosomatic Research Smets, Ema; Garssen, B; Bonke, B; Dehaes, Jcjm |
| 47. | Mechanisms of disease – The many roles of chemokines and chemokine receptors in inflammation 618 times cited 2006 New England Journal Of Medicine Charo, If; Ransohoff, Rm |
| 48. | Gene-microarray analysis of multiple sclerosis lesions yields new targets validated in autoimmune encephalomyelitis 617 times cited 2002 Nature Medicine Lock, C; Hermans, G; Pedotti, R; Brendolan, A; Schadt, E; Garren, H; Langer-Gould, A; Strober, S; Cannella, B; Allard, J; Klonowski, P; Austin, A; Lad, N; Kaminski, N; Galli, Sj; Oksenberg, Jr; Raine, Cs; Heller, R; Steinman, L |
| 49. | IDENTIFICATION OF LYMPHOTOXIN AND TUMOR-NECROSIS-FACTOR IN MULTIPLE-SCLEROSIS LESIONS 597 times cited 1991 Journal Of Clinical Investigation Selmaj, K; Raine, Cs; Cannella, B; Brosnan, Cf |
| 50. | Placebo-controlled multicentre randomised trial of interferon beta-1b in treatment of secondary progressive multiple sclerosis 597 times cited 1998 Lancet Kappos, L; Polman, C; Pozzilli, C; Thompson, A; Dahlke, F; Knight, R; Hern, J; Coleman, R; Gerrie, L; Cooper, G; Moore, J; Boringa, J; Van Oosten, B; Ronner, H; Schrijver, H; Truyen, L; Montalban, J; Rio, J; Tintore, M; Jacas, C; Marzo, E; Lechner-Scott, J; Huber, S; Lienert, C; Brunnschweiler, H; Hawkins, S; Droogan, A; Mcdonnell, G; Duddy, M; Mckinstry, S; Altenkirch, H; Baum, K; Einhaupl, K; Marx, P; Poewe, W; Walter, G; Akman, H; Brockmeier, B; Scherer, P; Zschenderlein, R; Schmierer, K; Gelderblom, H; Hartmann, A; Stapf, C; Luschow, A; Mackert, B; Schumacher, H; Masuhr, F; Hempel, T; Zimmermann, R; Munch, M; Francis, D; Heafield, M; Al-Memar, A; Winer, J; Chong, M; Brochet, B; Gayou, A; Auriacombe, S; Dousset, V; Wiles, C; Thomas, F; Pickersgill, T; Hinds, N; Dawson, K; Hughes, T; Hutchinson, M; Murphy, R; Redmond, J; Webb, S; Stoll, G; Jander, S; Hagemann, G; Koller, H; Hanemann, C; Kolmel, H; Reichel, D; Petereit, K; Thieme, A; Khatami, A; Neumann, M; Amaducci, L; Massacesi, L; Siracusa, G; Amato, M; Bartolozzi, L; Repice, A; Minderhoud, J; De Keyser, J; Zorgdrager, A; Zwanikken, C; Poser, S; Polak, T; Gunther, A; Bitsch, A; Borner, T; Weber, F; Wikstrom, J; Farkkila, M; Majuri, H; Sumelahti, M; Telakivi, T; Fredrikson, S; Martin, C; Miller, D; O’Riordan, J; Brex, P; Kapoor, R; Werring, D; Confavreux, C; Brunet, P; Hannoun, D; Brudon, F; Moreau, T; Blanc, S; D’Hooghe, M; Jacobs, K; Lissoir, F; Demonty, L; Comi, G; Colombo, B; Rossi, P; Rodegher, M; Santuccio, G; Martinelli, F; Hohlfeld, R; Walther, E; Goebels, N; Dang, T; Lindert, R; Voltz, R; Cartlidge, N; Bates, D; Moran, G; Pandit, L; Westwood, M; Haller, P; Sommer, J; Bitter, J; Suss, F; Mellies, J; Mucha, P; Lyon-Caen, O; Degos, Jd; Roullet, E; Lubetzki, C; Creange, A; Tourbah, A; Pez, D; Lecanuet, P; Nicolt, P; Edan, G; Belliard, S; De Marco, O; Cahagne, V; De Burghgraeve, V; Brunet, I; Fieschi, C; Millefiorini, E; Gasperini, C; Buttinelli, C; Frontini, M; Howell, S; Hadjivassiliou, M; Gibson, A; Graham, A; Harkness, K; Lawden, M; Clanet, M; Wauban, E; Azais-Vuillemin, C; Lau, Gkk; Louis, C; Panelius, M; Ruutiainen, J; Eralinna, J; Soilu-Hanninen, M; Gold, R; Hartung, Hp; Jung, S; Bayas, A; Flachenecker, P; Weilbach, F; Archelos, J; Kollegger, H; Vass, K; Asenbaum, S; Chatsakos, T; Beckmann, K; Ghazi, M; Wagner, K; Miltenburger, C; Mcfarland, H; Petkau, J; Sabouraud, O; Toyka, K |
Tabelle: Die 50 meistzitierten Multiple Sklerose Publikationen. Datenquelle: Web of Science, Stand: 30.08.2011
Methode
Ich habe folgende Suchanfrage im Web of Science verwendet:
- Topic=(multiple AND sclerosis)
- Refined by: Document Type=( ARTICLE OR EDITORIAL MATERIAL OR REVIEW OR PROCEEDINGS PAPER OR LETTER )
- Keine zeitliche Einschränkung.
Diskussion
Interessanterweise sind die Top 3 der zitierten Werke keine Forschungsresultate, sondern Forschungsanleitungen und -richtlinien.
Ludwig Kappos von der Universität Basel und Norbert Goebels konnte ich als Schweizer Forscher in dieser Liste finden. Prof. Dr. Ludwig Kappos hat an den Publikationen Nr. 13, 14, 45 und 50 mitgearbeitet.
Von der DMSG sind die Herren Hans-Peter Hartung, Ralf Gold, Klaus V. Toyka und Reinhard Hohlfeld in der Tabelle enthalten.
